U.S. health regulator plans ‘thorough’ probe of St. Jude case – Business Insider

U.S. health regulator plans 'thorough' probe of St. Jude case
Business Insider
The ticker and trading information for St. Jude Medical is displayed where the stock is traded on the floor of the NYSE Thomson Reuters. By Jim Finkle. (Reuters) – The U.S. Food and Drug Administration plans a "thorough investigation" of allegations …
Hedge Fund and Cybersecurity Firm Team Up to Short-Sell Device MakerNew York Times
Lawyers Say St. Jude's Lawsuit Against Short-Seller Faces Steep ClimbInsurance Journal
St. Jude Says Short-Seller Profited on Patient FearsCourthouse News Service
CNBC –Wall Street Journal –Minneapolis Star Tribune –Bloomberg
all 81 news articles »